Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
International Journal of Nanomedicine|February 18, 2010
Nanoparticulate Quillaja saponin induces apoptosis in human leukemia cell lines with a high therapeutic indexKefei Hu, Saideh Berenjian, Rolf Larsson, et al.
The Journal of Dairy Research|November 23, 2012
Immune response of heifers against a Staphylococcus aureus CP5 whole cell vaccine formulated with ISCOMATRIX™ adjuvantCecilia M Camussone, Carolina M Veaute, Carina Porporatto, et al.
Research in Veterinary Science|November 12, 2013
Immune response of heifers against a Staphylococcus aureus CP5 whole cell and lysate vaccine formulated with ISCOM Matrix adjuvantCecilia M Camussone, Carolina M Veaute, Nazarena Pujato, et al.
FEMS Immunology and Medical Microbiology|February 1, 2005
The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP703Ke-Fei Hu, Matthias Regner, Claire-Anne Siegrist, et al.
Microbes and Infection|May 26, 2004
Safety and efficacy of immune-stimulating complex-based antigen delivery systems for neonatal immunisation against respiratory syncytial virus infectionMatthias Regner, Fiona Culley, Paola Fontannaz, et al.
Vaccine|November 16, 2004
Bovine respiratory syncytial virus ISCOMs--protection in the presence of maternal antibodiesSara Hägglund, Ke-Fei Hu, Lars Erik Larsen, et al.
Vaccine|January 27, 2004
Neutralization of primary HIV-1 SF13 can be detected in extended incubation phase assays with sera from monkeys immunized with recombinant HIV-1 SF2 gp120David Davis, Helen Donners, Betty Willems, et al.
Clinical and Vaccine Immunology : CVI|January 29, 2010
An oral versus intranasal prime/boost regimen using attenuated human rotavirus or VP2 and VP6 virus-like particles with immunostimulating complexes influences protection and antibody-secreting cell responses to rotavirus in a neonatal gnotobiotic pig modelMarli S P Azevedo, Ana Maria Gonzalez, Lijuan Yuan, et al.
Clinical and Vaccine Immunology : CVI|April 11, 2006
High titers of circulating maternal antibodies suppress effector and memory B-cell responses induced by an attenuated rotavirus priming and rotavirus-like particle-immunostimulating complex boosting vaccine regimenTrang V Nguyen, Lijuan Yuan, Marli S P Azevedo, et al.
Vaccine|December 20, 2005
Low titer maternal antibodies can both enhance and suppress B cell responses to a combined live attenuated human rotavirus and VLP-ISCOM vaccineTrang V Nguyen, Lijuan Yuan, Marli S P Azevedo, et al.
Pageof 3